The continued solid uptake of Cardinal Health's products is expected to have driven fiscal third-quarter revenues despite an uncertain macroeconomic environment.
Evaluate the expected performance of Cardinal (CAH) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
![]() CAH In 2 months Estimated | Quarterly | $0.51 Per Share |
![]() CAH 4 weeks ago Paid | Quarterly | $0.51 Per Share |
![]() CAH 3 months ago Paid | Quarterly | $0.51 Per Share |
![]() CAH 6 months ago Paid | Quarterly | $0.51 Per Share |
![]() CAH 9 months ago Paid | Quarterly | $0.51 Per Share |
![]() CAH 28 Mar 2024 Paid | Quarterly | $0.5 Per Share |
30 Apr 2025 30 Apr 2025 Date | | - Cons. EPS | - EPS |
30 Jan 2025 Date | | 1.76 Cons. EPS | 1.93 EPS |
1 Nov 2024 Date | | 1.62 Cons. EPS | 1.88 EPS |
14 Aug 2024 Date | | 1.73 Cons. EPS | 1.84 EPS |
13 Aug 2024 Date | | 1.73 Cons. EPS | - EPS |
![]() CAH In 2 months Estimated | Quarterly | $0.51 Per Share |
![]() CAH 4 weeks ago Paid | Quarterly | $0.51 Per Share |
![]() CAH 3 months ago Paid | Quarterly | $0.51 Per Share |
![]() CAH 6 months ago Paid | Quarterly | $0.51 Per Share |
![]() CAH 9 months ago Paid | Quarterly | $0.51 Per Share |
![]() CAH 28 Mar 2024 Paid | Quarterly | $0.5 Per Share |
30 Apr 2025 30 Apr 2025 Date | | - Cons. EPS | - EPS |
30 Jan 2025 Date | | 1.76 Cons. EPS | 1.93 EPS |
1 Nov 2024 Date | | 1.62 Cons. EPS | 1.88 EPS |
14 Aug 2024 Date | | 1.73 Cons. EPS | 1.84 EPS |
13 Aug 2024 Date | | 1.73 Cons. EPS | - EPS |
Medical Distribution Industry | Healthcare Sector | Mr. Jason M. Hollar CEO | NYSE Exchange | 14149Y108 Cusip |
Germany Country | - Employees | 1 Apr 2025 Last Dividend | 23 Apr 2001 Last Split | 31 Dec 1987 IPO Date |
Cardinal Health, Inc. is a prominent provider of healthcare services and products with a global presence, including operations in the United States, Canada, Europe, Asia, and other international territories. The company caters to a wide range of healthcare needs by offering customized solutions specifically designed for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and also for patients at home. With its foundation laid in 1979 and having its headquarters in Dublin, Ohio, Cardinal Health is organized into two main segments: Pharmaceutical and Medical, through which it facilitates an extensive array of health care products and services.
The company's operations are broadly categorized into two segments, each offering a variety of products and services.
This segment involves the distribution of branded and generic pharmaceuticals, specialty pharmaceutical and over-the-counter healthcare and consumer products. It extends its services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products. The operations include running nuclear pharmacies, radiopharmaceutical manufacturing facilities, repackaging generic pharmaceuticals and over-the-counter healthcare products, and providing pharmacy management services to hospitals. This broad range ensures a steady supply of essential drugs and healthcare products to various healthcare providers.
Under this segment, Cardinal Health manufactures, sources, and distributes an array of branded medical, surgical, and laboratory products. The list includes: